Dr_Rosalind_Achebe
Nephrology. FLOW changed my clinic. Ask me about the eGFR dip.
69kreputation
232answers
30accepted
5questions
1·4·7badges g·s·b
86tags
107Is ALT a better monitoring choice than AST on survodutide?accepted · answered 23 Apr 2025 · bloodwork, kidney-function, lipids100What did the placebo arm of SUSTAIN-6 report for reflux?accepted · answered 12 Jan 2025 · clinical-trials, gi-side-effects99Is an 18G drawing needle the right choice for drawing survodutide at 8 mg/mL?answered 8 Feb 2025 · needle-gauge, injection-technique, dead-space96Why would Janoshik report 97.6% where the supplier certificate says something higher?answered 20 Nov 2024 · purity, hplc, batch-testing93What would you ask WuXi TIDES before a first order that they cannot fake?answered 6 May 2024 · vendor-vetting, coa, batch-testing92What does PIONEER-4 actually establish about oral semaglutide?accepted · answered 13 Mar 2025 · clinical-trials, semaglutide, cardiovascular91My eGFR fell from 85 to 74 eight weeks in. Is that the expected dip or actual injury?accepted · answered 30 Nov 2024 · kidney-function, bloodwork, hydration86What does a 99.1% purity with a lot-specific certificate attached let me conclude?answered 21 Apr 2025 · purity, coa, hplc84What did the placebo arm of SURMOUNT-1 report for vomiting?accepted · answered 14 Oct 2025 · clinical-trials, vomiting81Does cystatin C tell me anything about hepatic fat on survodutide?answered 30 Apr 2025 · liver-enzymes, mash, bloodwork77Is there any published stability data for tirzepatide at room temperature?answered 12 Feb 2025 · peptide-stability, storage, clinical-trials71Is eGFR worth drawing at baseline before starting retatrutide?answered 12 Mar 2025 · bloodwork, harm-reduction, a1c69What does the mechanism of tirzepatide predict that SURPASS-3 did not test?answered 23 Dec 2024 · glp1-mechanism, clinical-trials, gip-receptor68Why is albuminuria described as more informative than eGFR at a normal eGFR?answered 28 Jun 2026 · kidney-function, renal-outcomes, bloodwork67Is SURMOUNT-OSA a fair comparison of tirzepatide against its comparator arm?accepted · answered 1 Apr 2026 · clinical-trials, semaglutide, tirzepatide66How many freeze-thaw cycles will retatrutide at 5 mg/mL tolerate?answered 9 May 2025 · freeze-thaw, peptide-stability, storage66What is the reported incidence of reflux on retatrutide in TRIUMPH-3?accepted · answered 23 Aug 2025 · gi-side-effects, clinical-trials, retatrutide65Is 97.6% a realistic purity ceiling for dulaglutide given its chain length?answered 13 May 2025 · purity, hplc, peptide-mapping64Is a lot-specific certificate from SWB sufficient basis to skip independent testing?answered 12 Mar 2026 · coa, batch-testing, harm-reduction63What does SURMOUNT-5 tell me about reflux at the 15 mg dose?answered 23 Oct 2024 · clinical-trials, gi-side-effects, titration62Does creatinine tell me anything about hepatic fat on a GLP-1 receptor agonist?answered 20 Oct 2024 · liver-enzymes, mash, bloodwork62Is 97.6% a realistic purity ceiling for ecnoglutide given its chain length?answered 4 Dec 2024 · purity, hplc, peptide-mapping62What did the placebo arm of TRIUMPH-3 report for dizziness?accepted · answered 12 Dec 2025 · clinical-trials, harm-reduction62What fraction of loss on oral semaglutide is lean mass according to PIONEER-4?answered 23 Apr 2025 · lean-mass, muscle-loss, dexa60Does GGT tell me anything about hepatic fat on oral semaglutide?answered 2 Sept 2024 · liver-enzymes, mash, bloodwork59How do I compare WXT and JEEP on lead time to Finland?answered 1 Apr 2025 · vendor-comparison, international-shipping, cold-chain58Is potassium a better monitoring choice than lipase on a GLP-1 receptor agonist?answered 15 Nov 2024 · bloodwork, kidney-function, lipids57What did the trials do with participants who could not tolerate a dose step?accepted · answered 1 Mar 2025 · titration, clinical-trials, gi-side-effects55Does racemisation dominate for retatrutide held at 4 °C?answered 2 Jun 2025 · peptide-stability, storage, hplc53Is GGT a better monitoring choice than albumin-to-creatinine ratio on retatrutide?answered 17 May 2024 · bloodwork, kidney-function, lipids53My liraglutide vial sat at room temperature for fourteen days — is testing worth it before use?answered 27 Jan 2026 · cold-chain, peptide-stability, batch-testing53What does SURMOUNT-5 actually establish about tirzepatide?answered 1 Jun 2024 · clinical-trials, semaglutide, cardiovascular50Is 12.5 mg weekly a defensible maintenance dose for liraglutide?answered 11 Mar 2026 · maintenance-dose, clinical-trials, dosing-math50What does SURMOUNT-5 tell me about reflux at the 15 mg dose?answered 3 Nov 2024 · clinical-trials, gi-side-effects, titration49Does creatinine tell me anything about hepatic fat on cagrilintide?answered 6 Nov 2024 · liver-enzymes, mash, bloodwork49How comparable are oral semaglutide and semaglutide on the evidence available?accepted · answered 30 Jul 2024 · clinical-trials, semaglutide, tirzepatide49Why did my lipase move after two weeks on ecnoglutide?accepted · answered 22 Jun 2026 · bloodwork, kidney-function, lipids48Does the SURMOUNT-3 population resemble anyone asking about tirzepatide here?answered 21 Jun 2024 · clinical-trials, harm-reduction, semaglutide47Does hydrolysis of orforglipron at 40 °C show up as a loss of content or of purity?answered 11 Jun 2024 · peptide-stability, content-assay, purity47Is LDL-C a better monitoring choice than triglycerides on semaglutide?answered 8 Sept 2024 · bloodwork, kidney-function, lipids47What is the thermal exposure on a Xi’an to the Netherlands lane in summer?answered 27 Nov 2025 · cold-chain, international-shipping, storage46What does the mechanism of cagrilintide predict that REDEFINE-1 did not test?accepted · answered 16 Jul 2025 · glp1-mechanism, clinical-trials, gip-receptor43Is eGFR a better monitoring choice than HbA1c on liraglutide?accepted · answered 28 May 2024 · bloodwork, kidney-function, lipids43What did the placebo arm of SURMOUNT-4 report for constipation?accepted · answered 19 May 2025 · clinical-trials, constipation43What does SOUL tell me about reflux at the 7 mg dose?accepted · answered 19 Apr 2024 · clinical-trials, gi-side-effects, titration43Why did my potassium move after three weeks on a GLP-1 receptor agonist?answered 8 Jan 2025 · bloodwork, kidney-function, lipids42Why did my GGT move after four weeks on retatrutide?answered 18 Apr 2026 · bloodwork, kidney-function, lipids42Why do two papers on SELECT report different headline figures?answered 19 Jul 2024 · clinical-trials, dosing-math, semaglutide41How do I convert the REDEFINE-1 hazard ratio into an absolute risk reduction?answered 11 May 2025 · cardiovascular, clinical-trials, dosing-math41What did the placebo arm of STEP 1 report for constipation?answered 4 Aug 2024 · clinical-trials, constipation41Would you accept 99.1% on retatrutide from QYB without a content assay?answered 14 Mar 2026 · purity, content-assay, vendor-vetting40How does personal-importation discretion work in the United Kingdom?answered 26 Sept 2025 · import-regulations, customs, research-use-only40Is 8 mg/mL a sensible working concentration for survodutide, or should I go lower?answered 22 Oct 2024 · diluent-volume, reconstitution, dosing-math40What interval makes sense for repeating albumin-to-creatinine ratio on retatrutide?answered 14 Jun 2024 · bloodwork, harm-reduction, a1c40Why did my lipase move after two weeks on survodutide?answered 11 Mar 2026 · bloodwork, kidney-function, lipids39Is an insulated cool box good enough for storing reconstituted tirzepatide?answered 11 Dec 2024 · storage, cold-chain, harm-reduction39What interval makes sense for repeating creatinine on a GLP-1 receptor agonist?accepted · answered 22 Sept 2024 · bloodwork, harm-reduction, a1c39Why did my creatinine move after two weeks on survodutide?answered 23 Sept 2025 · bloodwork, kidney-function, lipids38What did the placebo arm of FLOW report for reflux?answered 26 Sept 2025 · clinical-trials, gi-side-effects38What does PIONEER-4 tell me about reflux at the 7 mg dose?accepted · answered 30 Nov 2025 · clinical-trials, gi-side-effects, titration37Is TSH a better monitoring choice than magnesium on tirzepatide?answered 24 Mar 2026 · bloodwork, kidney-function, lipids37What did STEP 4 do with participants who could not tolerate a step?answered 18 Feb 2025 · titration, clinical-trials, gi-side-effects37What is the reported incidence of headache on semaglutide in STEP 5?answered 2 Apr 2024 · clinical-trials, harm-reduction, semaglutide36A COA says 99.2% purity and 6.1 mg content — is that contradictory?answered 5 May 2026 · coa, purity, content-assay36What does SOUL tell me about headache at the 25 mg dose?accepted · answered 18 Jul 2026 · clinical-trials, titration36What does SURPASS-2 report at the 10 mg dose level?answered 7 May 2025 · clinical-trials, dosing-math, titration36What is the reported incidence of hair thinning on a GLP-1 receptor agonist in STEP 3?answered 24 May 2025 · hair-loss, clinical-trials36Why did my cystatin C move after three weeks on cagrilintide?answered 5 Aug 2025 · bloodwork, kidney-function, lipids36Why did my LDL-C move after eight weeks on ecnoglutide?answered 12 May 2025 · bloodwork, kidney-function, lipids35Does dizziness at week seven of cagrilintide usually resolve without a dose change?answered 14 Jul 2026 · titration, harm-reduction, amylin35How much protein in grams do I need at 74 kg on 1,400 kcal a day?answered 12 May 2026 · protein-intake, nutrition, lean-mass35Is 0.5 mg weekly a defensible maintenance dose for dulaglutide?answered 7 Jun 2025 · maintenance-dose, clinical-trials, dosing-math34How do I convert the SURMOUNT-2 hazard ratio into an absolute risk reduction?answered 23 Dec 2024 · cardiovascular, clinical-trials, dosing-math34What counter-ion should I expect on an ERP cagrilintide lot?answered 2 Jun 2026 · acetate-content, purity, content-assay34What did the placebo arm of REDEFINE-1 report for reflux?answered 2 Dec 2025 · clinical-trials, gi-side-effects34What did the placebo arm of SURMOUNT-2 report for headache?accepted · answered 28 Jul 2026 · clinical-trials, harm-reduction34What does the mechanism of semaglutide predict that STEP 5 did not test?answered 6 Dec 2024 · glp1-mechanism, clinical-trials, gip-receptor34What is the reported incidence of dizziness on oral semaglutide in PIONEER-1?answered 15 Sept 2024 · clinical-trials, harm-reduction, oral-glp134Why did my magnesium move after twelve weeks on dulaglutide?accepted · answered 4 Nov 2025 · bloodwork, kidney-function, lipids33How do I convert the STEP 1 hazard ratio into an absolute risk reduction?answered 2 Jan 2026 · cardiovascular, clinical-trials, dosing-math33How much product does syringe dead space actually cost me? Fixed-needle versus luer-lock, in µL and mganswered 2 Dec 2024 · dead-space, insulin-syringe, dosing-math33Is 37 °C an acceptable storage condition for lyophilised tirzepatide?answered 2 Dec 2024 · storage, peptide-stability, shelf-life33Is eGFR worth drawing at baseline before starting orforglipron?answered 13 Jul 2025 · bloodwork, harm-reduction, a1c33Why did my ApoB move after sixteen weeks on tirzepatide?answered 10 Feb 2025 · bloodwork, kidney-function, lipids32Does a slower rate of loss reduce gallstone risk in practice?answered 17 Dec 2024 · gallbladder, gi-side-effects, clinical-trials32How do I convert the TRIUMPH-1 hazard ratio into an absolute risk reduction?answered 18 Nov 2024 · cardiovascular, clinical-trials, dosing-math32Is a 27G needle the right choice for drawing liraglutide at 1 mg/mL?answered 26 Mar 2026 · needle-gauge, injection-technique, dead-space32Is resistance training six times a week enough at 1,200 kcal a day?answered 22 May 2026 · resistance-training, lean-mass, exercise32What did the placebo arm of SURMOUNT-2 report for hair thinning?answered 18 Dec 2024 · clinical-trials, hair-loss32What does ESSENCE actually establish about semaglutide?answered 26 Aug 2024 · clinical-trials, semaglutide, cardiovascular32Why is the early eGFR dip expected rather than alarming?answered 25 Jun 2025 · renal-outcomes, kidney-function, hydration31What did the placebo arm of ATTAIN-1 report for constipation?accepted · answered 30 Mar 2025 · clinical-trials, constipation31Why did my ALT move after eight weeks on survodutide?answered 16 Feb 2026 · bloodwork, kidney-function, lipids30Does the STEP 2 population resemble anyone asking about semaglutide here?answered 25 Apr 2025 · clinical-trials, harm-reduction, semaglutide30How do I read an impurity table on a survodutide certificate against the 97.9% headline?answered 12 Dec 2024 · purity, coa, hplc30Is a WWB order from Shanghai likely to hold cold chain to Norway?answered 5 Jul 2024 · cold-chain, international-shipping, vendor-comparison29Is there an honest apples-to-apples comparison of the STEP and SURMOUNT headline results?answered 27 Apr 2025 · semaglutide, tirzepatide, clinical-trials29Does reflux at week three of a GLP-1 receptor agonist usually resolve without a dose change?answered 26 Jul 2024 · gi-side-effects, titration29Is 0.25 mg weekly a defensible maintenance dose for liraglutide?answered 22 Apr 2025 · maintenance-dose, clinical-trials, dosing-math29Is 25 mg weekly a defensible maintenance dose for oral semaglutide?answered 3 Feb 2025 · maintenance-dose, clinical-trials, dosing-math28Is 50 mg in 3 mL of phosphate-buffered diluent a sensible presentation for dulaglutide?answered 1 Jan 2025 · diluent-volume, reconstitution, dosing-math28Is creatinine worth drawing at baseline before starting mazdutide?answered 8 Jul 2026 · bloodwork, harm-reduction, a1c28What does SOUL tell me about reflux at the 7 mg dose?answered 8 Apr 2024 · clinical-trials, gi-side-effects, titration28Why would PeptideMeter report 97.1% where the supplier certificate says something higher?answered 21 May 2026 · purity, hplc, batch-testing27Does fatigue at week nine of a GLP-1 receptor agonist usually resolve without a dose change?answered 15 Nov 2024 · fatigue, titration27How much protein in grams do I need at 112 kg on 1,000 kcal a day?answered 12 Dec 2024 · protein-intake, nutrition, lean-mass27Is AST a better monitoring choice than ALT on mazdutide?answered 10 Apr 2025 · bloodwork, kidney-function, lipids27What does SOUL tell me about vomiting at the 14 mg dose?answered 15 Oct 2025 · clinical-trials, vomiting, titration27What does STEP 4 tell me about early satiety at the 1 mg dose?answered 3 Mar 2026 · clinical-trials, gi-side-effects, titration27What should be in place before a first ecnoglutide vial arrives from Qingdao?answered 15 Feb 2026 · harm-reduction, research-use-only, sterility26Is a TFC order from Tianjin likely to hold cold chain to the United Kingdom?answered 8 Dec 2024 · cold-chain, international-shipping, vendor-comparison25Is SOUL a fair comparison of oral semaglutide against its comparator arm?answered 24 Aug 2025 · clinical-trials, semaglutide, tirzepatide25What did the placebo arm of PIONEER-1 report for early satiety?answered 30 Mar 2026 · clinical-trials, gi-side-effects25What did the placebo arm of SURMOUNT-OSA report for reflux?answered 16 Feb 2026 · clinical-trials, gi-side-effects25What does FLOW tell me about headache at the 2 mg dose?answered 12 Aug 2025 · clinical-trials, titration24Does creatinine tell me anything about hepatic fat on a GLP-1 receptor agonist?answered 4 Jan 2025 · liver-enzymes, mash, bloodwork24How comparable are tirzepatide and liraglutide on the evidence available?answered 20 Feb 2025 · clinical-trials, semaglutide, tirzepatide24Is there any published stability data for liraglutide at minus 80 °C?answered 1 Nov 2024 · peptide-stability, storage, clinical-trials23How is albuminuria regression measured across a trial?answered 4 Aug 2025 · renal-outcomes, kidney-function, clinical-trials23Is HbA1c a better monitoring choice than eGFR on orforglipron?answered 1 Feb 2025 · bloodwork, kidney-function, lipids